Voltaren

GlaxoSmithKline is acquiring the Novartis f consumer healthcare division for $13 billion. The purchase gives Glaxo full control of products that include Voltaren for muscle pain, Senosdyne toothpaste, Panadol for headaches and other Novartis products.